Literature DB >> 22481463

Acetylcholinesterase and butyrylcholinesterase as markers of low-grade systemic inflammation.

Undurti N Das.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22481463

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN： 1665-2681            Impact factor:   2.400


× No keyword cloud information.
  13 in total

Review 1.  Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Gohar Mushtaq; Nigel H Greig; Jalaluddin A Khan; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

2.  Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase.

Authors:  Sidra Batool; Muhammad Sulaman Nawaz; Nigel H Greig; Mohd Rehan; Mohammad A Kamal
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2013

3.  Metformin/Donepezil combination modulates brain antioxidant status and hippocampal endoplasmic reticulum stress in type 2 diabetic rats.

Authors:  Tajudeen Olabisi Obafemi; Oluwaseun R Olasehinde; Oyindamola A Olaoye; Kikelomo F Jaiyesimi; Funmilayo D Adewumi; Olusola B Adewale; Blessing A Afolabi
Journal:  J Diabetes Metab Disord       Date:  2020-05-16

Review 4.  Mechanistic interplay of various mediators involved in mediating the neuroprotective effect of daphnetin.

Authors:  Lovedeep Singh; Amrit Pal Singh; Rajbir Bhatti
Journal:  Pharmacol Rep       Date:  2021-04-16       Impact factor: 3.024

5.  Assessment of platelets morphological changes and serum butyrylcholinesterase activity in children with diabetic ketoacidosis: a case control study.

Authors:  Suzan Omar Mousa; Samira Zein Sayed; Mahmoud Mohammed Moussa; Ahmed Hamdy Hassan
Journal:  BMC Endocr Disord       Date:  2017-04-04       Impact factor: 2.763

Review 6.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

7.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

8.  New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter.

Authors:  Joanna Jońca; Monika Żuk; Bartosz Wasąg; Anna Janaszak-Jasiecka; Krzysztof Lewandowski; Bartosz Wielgomas; Krzysztof Waleron; Jacek Jasiecki
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

9.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  Increased acetylcholine esterase activity produced by the administration of an aqueous extract of the seed kernel of Thevetia peruviana and its role on acute and subchronic intoxication in mice.

Authors:  Rubén Marroquín-Segura; Ricardo Calvillo-Esparza; José Luis Alfredo Mora-Guevara; José Horacio Tovalín-Ahumada; Abigail Aguilar-Contreras; Vicente Jesús Hernández-Abad
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.